Express Scripts bars new launches from Lilly, Merck and shuts out Novo for 2017

For the third year in a row, Express Scripts unveiled a new national formulary excluding dozens of drugs. And for the third year in a row, a short list of winners and losers comprises some of Big Pharma’s biggest launches.

Spotlight

Spotlight

Related News